[1]张伟健,黄彦子,陈新博,等.郭绍举主任运用水湿内停方治疗肠易激综合征的经验[J].西部中医药,2022,35(03):57-60.[doi:10.12174/j.issn.2096-9600.2022.03.13]
　ZHANG Weijian,HUANG Yanzi,CHEN Xinbo,et al.Director Guo Shaoju’s Experience in Treating Diarrhea-predominant Irritable Bowel Disease by Water-damp Internal Retention Prescription[J].Western Journal of Traditional Chinese Medicine,2022,35(03):57-60.[doi:10.12174/j.issn.2096-9600.2022.03.13]
点击复制

郭绍举主任运用水湿内停方治疗肠易激综合征的经验
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年03期
页码:
57-60
栏目:
出版日期:
2022-03-15

文章信息/Info

Title:
Director Guo Shaoju’s Experience in Treating Diarrhea-predominant Irritable Bowel Disease by Water-damp Internal Retention Prescription
作者:
张伟健1, 黄彦子1, 陈新博1, 李海文2, 康建媛2, 李京伟2, 指导：郭绍举,
1.广州中医药大学第四临床医学院，广东 深圳 518033
2.深圳市中医院
Author(s):
ZHANG Weijian1, HUANG Yanzi1, CHEN Xinbo1, LI Haiwen2, KANG Jianyuan2, LI Jingwei2, Shaoju Director:GUO,
1.The Forth Clinical Medical School of Guangzhou University of Chinese Medicine, Shenzhen 518033, China
2.Shenzhen Hospital of TCM
关键词:
肠易激综合征; 腹泻型; 脾肾阳虚; 水湿内停方
Keywords:
irritable bowel disease;  diarrhea-predominant type; spleen-kidney deficiency; water-damp internal retention prescription
分类号:
R259
DOI:
10.12174/j.issn.2096-9600.2022.03.13
文献标志码:
A
摘要:
郭绍举主任认为肠易激综合征患者总以脾肾阳虚为本，水湿内停为标，或兼夹郁及生风、化瘀，治疗当以健脾温肾、分利水湿、涩肠止泻为法，同时其基于“火生土、土伏火、土治水”理论自拟水湿内停方加减治疗肠易激综合征方证相印，切中病机。
Abstract:
Director Guo Shaoju thinks that the patients suffering irritable bowel disease (IBD) are based on spleen-kidney Yang deficiency and marked by water-damp internal retention, or complicated by mixed stagnation, generated wind and transformed stagnation, he adopts invigorating spleen and warming kidney, removing water-damp, relieving diarrhea with astringents as therapeutic methods. Director Guo Shaoju made water-damp internal retention prescription based on the theory of “fire generating earth, earth subduing fire and earth governing water” for IBS, the prescription matches the pattern and strikes the pathogenesis.

相似文献/References:

[1]信 楠,杨培培 指导：沈舒文.健脾导滞汤治疗肠易激综合征30例[J].西部中医药,2012,25(10):91.
　XIN Nan,YANG Pei-pei Director: SHEN Shu-wen.JianPi DaoZhiTang in Treating 30 Cases of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2012,25(03):91.
[2]张晓宁,马玉侠.隔药灸脐与匹维溴铵对脾虚型肠易激综合征患者尿液代谢组学影响的异同[J].西部中医药,2015,28(07):1.
[3]杨磊,孙洁,李滢,等.电针对IBS模型大鼠肠系膜微血管管径与血浆CGRP、VIP水平的影响*[J].西部中医药,2014,27(03):22.
　YANG Lei,SUN Jie,LI Ying,et al.Influence of Acusector on the Levels of CGRP and VIP in the Plasma and Mesenteric Microvascular Caliber of IBS Rat Model[J].Western Journal of Traditional Chinese Medicine,2014,27(03):22.
[4]梁胜斌,杨世洁,李共信,等.敦煌葆元汤治疗肝郁脾虚型肠易激综合征的临床观察[J].西部中医药,2013,26(07):79.
　LIANG Shengbin,YANG Shijie,LI Gongxin,et al.Clinical Observation on DunHuang BaoYuanTang in Treating Irrirable Bowel Syndrome of Liver Qi Stagnation and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(03):79.
[5]贾晓东,鱼涛△.温中散外敷热疗法配合参苓白术散内服治疗脾胃虚弱腹泻型肠易激综合征疗效观察[J].西部中医药,2018,31(11):81.
　JIA Xiaodong,YU Tao.Clinical Observation on Heat Therapy of WenZhong Powder for External Application and Oral Administration of ShenLing BaiZhu Powder in the Treatment for IBS-D of Spleen-stomach Weakness Pattern[J].Western Journal of Traditional Chinese Medicine,2018,31(03):81.
[6]赵建民.姜黄-茴香胶囊治疗肠易激综合征70例[J].西部中医药,2018,31(12):63.
　ZHAO Jianmin.JiangHuang-HuiXiang Capsules in Treating 70 Cases of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2018,31(03):63.
[7]张媛媛,舒劲,雷珉.舒劲教授从肝脾论治便秘型肠易激综合征[J].西部中医药,2021,34(02):59.[doi:10.12174/j.issn.2096-9600.2021.02.15]
　ZHANG Yuanyuan,SHU Jin,LEI Min.Professor Shu Jin′s Experience in Treating Constipation Predominant Irritable Bowel Syndrome from Liver and Spleen[J].Western Journal of Traditional Chinese Medicine,2021,34(03):59.[doi:10.12174/j.issn.2096-9600.2021.02.15]
[8]王喜红,谢春娥,薛晓轩,等.肠易激综合征的中西医治疗进展[J].西部中医药,2020,33(03):156.[doi:10.12174/j.issn.1004-6852.2020.03.44]
　WANG Xihong,XIE Chune,XUE Xiaoxuan,et al.The Progress in the Treatment of Irritable Bowel Syndrome by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2020,33(03):156.[doi:10.12174/j.issn.1004-6852.2020.03.44]
[9]冯文林,伍海涛.经方治疗肠易激综合征研究概况[J].西部中医药,2021,34(01):134.[doi:10.12174/j.issn.2096-9600.2021.01.35]
　FENG Wenlin,WU Haitao.Research Overview of Classic Prescription in Treating Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2021,34(03):134.[doi:10.12174/j.issn.2096-9600.2021.01.35]
[10]耿琦,丛军.肠吉泰对肠易激综合征内脏高敏感大鼠PAR2、PKCε、TRPV1蛋白表达的影响[J].西部中医药,2022,35(04):60.[doi:10.12174/j.issn.2096-9600.2022.04.13]
　GENG Qi,CONG Jun.Effects of Changjitai Decoction on the Expressions of PAR2, PKCε and TRPV1 Protein in Visceral Hypersensitivity Rats with Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2022,35(03):60.[doi:10.12174/j.issn.2096-9600.2022.04.13]
[11]诸凡凡,叶 柏△.腹泻型肠易激综合征发病机制及治疗现状[J].西部中医药,2013,26(10):139.
　ZHU Fanfan,YE Bai.Current State of the Treatment and Pathogenesis of Diarrhea Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2013,26(03):139.
[12]周荣,彭琪,张敏.人参败毒散加味治疗腹泻型肠易激综合征 54 例[J].西部中医药,2014,27(08):52.
[13]牛立军,苏强,刘振伟,等.安肠止痛组方联合曲美布汀治疗腹泻型肠易激综合征 78 例[J].西部中医药,2014,27(08):81.
[14]张丽娜,刘则鹏,廖志峰.泻肝健脾补肾汤治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2014,27(09):120.
[15]寇媛,赵倩,闻新丽,等.中医三联疗法治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2015,28(11):79.
[16]曹俊,赵智强△.赵智强教授辨治腹泻型肠易激综合征经验介绍[J].西部中医药,2018,31(04):56.
　CAO Jun,ZHAO Zhiqiang.Professor Zhao Zhiqiang′s Experience of Differentiating and Treating Diarrhea-type Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2018,31(03):56.
[17]雷超芳,翟昌明,马重阳,等.王庆国教授辨治腹泻型肠易激综合征经验[J].西部中医药,2020,33(03):62.[doi:10.12174/j.issn.1004-6852.2020.03.17]
　LEI Chaofang,ZHAI Changming,MA Chongyang,et al.Professor Wang Qingguo's Experience in Differentiating and Treating Diarrhea - predominant Pattern Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2020,33(03):62.[doi:10.12174/j.issn.1004-6852.2020.03.17]
[18]张霞,范涛,袁惠,等.隔姜脐灸联合痛泻要方加减治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2023,36(03):131.[doi:10.12174/j.issn.2096-9600.2023.03.26]
　ZHANG Xia,FAN Tao,YUAN Hui,et al.Clinical Observation on Umbilical Moxibustion on Ginger Combined with Modified Tongxie Yaofang in the Treatment of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2023,36(03):131.[doi:10.12174/j.issn.2096-9600.2023.03.26]
[19]谢小玲,黄适,何锦轶,等.基于中医病因学说探讨HMGB1与IBS-D的相关性[J].西部中医药,2023,36(05):112.[doi:10.12174/j.issn.2096-9600.2023.05.26]
　XIE Xiaoling,HUANG Shi,HE Jinyi,et al.The Correlation between HMGB1 and IBS-D from the Etiology of TCM[J].Western Journal of Traditional Chinese Medicine,2023,36(03):112.[doi:10.12174/j.issn.2096-9600.2023.05.26]

备注/Memo

备注/Memo:
张伟健（1996—），男，在读硕士研究生。研究方向：脾胃系疾病的中医药防治。广东省自然科学基金（2017A030310601）；广东省中医药局面上科研项目（20191272）；深圳市卫生系统科研项目资助（201606023）；深圳市科技计划项目（JCYJ20160428175010774）。
更新日期/Last Update: 2022-06-24